"...a new Breaktrough for Primary Care"
Besieged from the combined burden of aging populations and
rising levels of Cardiovascular diseases (CVD), Primary Care is
reluctantly being thrust into the front lines of heartcare.
The first priority for enhancing Primary Care's role in front line
heartcare is technological innovation to create far more effective,
first-use, medical device better able to detect and diagnose onset,
earlier, of a wider range of heart diseases.
Because the more effective the Medical Device, the more
effective the Primary Care Practioner, the more able the
healthcare system is to meet the expectations of these growing
and aging "at-risk" populations.
CHART's "AI" is, the Physicians assistant.
They are the main point of contact with the patient with heart
disease. Yet their knowledge and experience with heart disease is
limited. CHART's AI helps them to provide objective assessment
and diagnostic interpretation support, and so bridge the gap
between Primary Care and Cardiology Care.
CHART helps better determine when the patient should be
reffered to the cardiologist, and why.
CHART provides the required medical justification.
And when not to refer the patient to the cardiologist, but when to
keep them in Primary Care, under preventative and pharmalogical
treatment options where treatments will be more affordable,
effective and safe for the patient.
State-of-the-Art ECG devices currently used in Primary Care
can only detect 44% of all common heart diseases prevalent
in Primary Care.
It's simple, ECG's technology is limited, as it can only detect
functions and dysfunctions of
an electrical nature.
By harnessing new breakthrough bio-signals more
characteristic of the hearts physiology and synchronizing
them with ECG, the CHART medical device system can
diagnose up to 94% of all common heart diseases, functions
CHART dramatically augments the GP's effectiveness in
CHART is the ideal heart diagnostic device for enabling
Cardiac-Telemedicine, because: First, it is able to cost-efficiently
support the widespread screening of symptomatic and
asymptomatic patient populations; and, Second, it more than
doubles the diagnostic effectiveness of existing devices.
Together, empowering Cardiac-Telemedicine into a truly viable
Tests can be locally conducted by easy to train medical
assistants. Physician can review the CHART report online with
the patient, confident they are getting the most thorough and
comprehensive cardiac status. And it must be, because remote
patients have limited access to corrective and treatment options.
Single-physician, nurse-practitioners, walk-in or community
clinics, whether urban or rural, all telemedicine accessible, all
patients now equal.
CHART is clinically proven. Reducing FN by up to 24%,
means sick patients are not sent home only to return with
worsened conditions requiring more expensive treatment
management. Reducing FP by up to 9%, means fewer healthy
patients are sent to Cardiology to undergo unnecessary and
often more costly and invasively riskier diagnostic procedures.
As heart disease goes undetected, so rises morbidity and
the resulting costs of heartcare. AI-Powered
Heartcare means patients are more effectively screened,
diagnosed and initially treated in Primary Care, a far more
cost-efficient level of care than Cardiology, greatly reducing